« Back to Record
Citation APA

Maertens, J., Lodewyck, T., Donnelly, P. J., Chantepie, S., Robin, C., Blijlevens, N., Turlure, P., Selleslag, D., Baron, F., Aoun, M., Heinz, W. W., Bertz, H., Ráčil, Z., Vandercam, B., Drgona, L., Coiteux, V., Llorente, C. C., Schaefer-Prokop, C., Paesmans, M., Ameye, L., Meert, L., Cheung, K.-J., Hepler, D. D., Loeffler, J., Barnes, R., Marchetti, O., Verweij, P. P., Lamoth, F., Bochud, P. Y., Schwarzinger, M., & Cordonnier, C. (2023). Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer. Clinical infectious diseases, 76(4), 674-682. doi:10.1093/cid/ciac623


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371031

Maertens, J., Lodewyck, T., Donnelly, P. J., Chantepie, S., Robin, C., Blijlevens, N., Turlure, P., Selleslag, D., Baron, F., Aoun, M., Heinz, W. W., Bertz, H., Ráčil, Z., Vandercam, B., Drgona, L., Coiteux, V., Llorente, C. C., Schaefer-Prokop, C., Paesmans, M., Ameye, L., Meert, L., Cheung, K.-J., Hepler, D. D., Loeffler, J., Barnes, R., Marchetti, O., Verweij, P. P., Lamoth, F., Bochud, P. Y., Schwarzinger, M., & Cordonnier, C. (2023). Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer. Clinical infectious diseases, 76(4), 674-682. doi:10.1093/cid/ciac623